Literature DB >> 14195855

INSULINOMA WITH SYMPTOMS FOR THIRTY YEARS.

K O BLACK, M A BIRNSTINGL.   

Abstract

Keywords:  BLOOD SUGAR; FASTING; GERIATRICS; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; ISLET CELL TUMOR; NEOPLASM DIAGNOSIS; OBESITY; SURGERY, OPERATIVE; TOLBUTAMIDE

Mesh：

Substances：

Year:  1964        PMID： 14195855      PMCID： PMC1898688     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  8 in total

1.  Islet cell tumors and hyperinsulinism.

Authors:  K W WARREN
Journal:  Surg Clin North Am       Date:  1962-06       Impact factor: 2.741

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  The diagnostic value of sodium tolbutamide in hypoglycemic states.

Authors:  S S FAJANS; J M SCHNEIDER; D E SCHTEINGART; J W CONN
Journal:  J Clin Endocrinol Metab       Date:  1961-04       Impact factor: 5.958

4.  Response to glucagon by subjects with hyperinsulinism from islet-cell tumours.

Authors:  V MARKS
Journal:  Br Med J       Date:  1960-05-21

5.  Clinical aspects of hyperinsulinism.

Authors:  H D BREIDAHL; E H RYNEARSON
Journal:  J Am Med Assoc       Date:  1956-01-21

6.  Islet cell tumors of the pancreas producing hypoglycemia.

Authors:  S F MARSHALL
Journal:  Surg Clin North Am       Date:  1958-06       Impact factor: 2.741

7.  Spontaneous hyper-insulism due to islet-cell adenoma.

Authors:  K O BLACK; J P HOSFORD; R S CORBETT; J W A TURNER
Journal:  Br Med J       Date:  1954-01-09

8.  Functioning pancreatic islet cell adenomas; a review of the literature and presentation of two new differential tests.

Authors:  E L CRAIN; G W THORN
Journal:  Medicine (Baltimore)       Date:  1949-12       Impact factor: 1.889
  8 in total
  1 in total

1.  Banting lecture 2011: hyperinsulinemia: cause or consequence?

Authors:  Barbara E Corkey
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.